NS

Nishtha Singh

Active Director Director DIN 09831995
DIN 09831995 First appointment Dec 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Nishtha Singh

Data last updated:

Nishtha Singh is a Director at Kolds Pharma Private Limited (since 2022). The company operates in Chemicals. Kolds Pharma Private Limited reported revenue of ₹2 Lakh (FY 2025).

DIN 09831995
Primary Designation Director
Industry Chemicals
First Appointment 21 Dec 2022
Oldest Company Age 25 yrs
Largest company Kolds Pharma Private Limited · ₹2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kolds Pharma Private Limited U24231DL2001PTC112785
Director21 Dec 20222001₹2 Lakh (FY 2025)Active

Board colleagues of Nishtha Singh

NameDINCompanyDesignation
Nishant Kumar Singh08436470Kolds Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kolds Pharma Private Limited
Premium access

Shareholding and investment profile for Nishtha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishtha Singh

Nishtha Singh currently holds 1 directorship: Kolds Pharma Private Limited (Director, since 21 Dec 2022, revenue ₹2 Lakh (FY 2025)).

Nishtha Singh was first appointed on 21 Dec 2022 as Director at Kolds Pharma Private Limited.

The current boards of Nishtha Singh's companies include Nishant Kumar Singh (Kolds Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available